Blog
Navigating the Complexities of Infant Nutrition Marketing
Dr Volker Spitzer, VP, Global Consumer Health R&D/RWE, IQVIA Consumer Health
Dr Stephanie Krammer-Lukas, Global Director, R&D and RWE Services, IQVIA Consumer Health
Khee Suan Bang, Associate Principal, Real World Solutions, IQVIA Consumer Health
Matt Stewart, Global Marketing Manager, IQVIA Consumer Health
Aug 08, 2024

The infant formula industry is at a crossroads, facing intense scrutiny over health claims and marketing practices. With a global market value of approximately $54 billion, the stakes are high for manufacturers to substantiate their claims with solid scientific evidence.

The Science Behind the Claims

Health claims on infant formula packaging are not mere marketing ploys; they are promises of nutritional benefits that support an infant's growth and development. These claims range from supporting brain development and immune system function to mimicking breast milk's nutritional profile. However, the challenge lies in the rigorous scientific validation required to back these claims. This process involves ethical considerations, methodological complexities, and regulatory hurdles that manufacturers must navigate.

Key Recommendations for the Industry

Addressing these challenges requires a strategic approach. Our up-coming white paper - Navigating Challenges in Marketing Infant Nutrition Products - will offer a deeper dive into what industry can do to overcome these challenges, but key areas of focus should be: enhancing research integrity, adopting innovative methodologies, engaging with stakeholders, and establishing standardized global regulations. The goal is to align research objectives with public health goals, promote ethical marketing practices, and ensure consumers can make informed decisions.

Utilizing Emerging Technologies

To support these recommendations, the industry can now also leverage emerging technologies. Advanced data analytics, including machine learning algorithms, are becoming instrumental in analyzing complex datasets related to infant nutrition. These tools can uncover patterns and correlations that traditional statistical methods might miss, providing deeper insights into the effects of various components of infant formulas on growth and development. Additionally, integrating social media listening strategies with generative artificial intelligence or natural language processing tools can help understand the sentiments and needs of parents and caregivers. Such insights are invaluable for refining study protocols, recruitment strategies, and educational campaigns, thereby enhancing engagement with the target audience.

Whitepaper
Navigating Challenges in Marketing Infant Nutrition Products

Want to dive deeper into the challenges and opportunities in infant nutrition marketing? Request your copy of our upcoming whitepaper Navigating Challenges in Marketing Infant Nutrition Products delivered straight to your inbox.
mother bottle feeding a baby
A Case for Decentralized Clinical Trials

A decentralized clinical trial conducted by IQVIA Consumer Health offers a glimpse into the future of infant formula research. The trial, which studied the growth patterns of infants fed with a new goat milk-based formula, leveraged digital tools for remote data collection, allowing for greater inclusivity and convenience for participants. 

Conclusion

As the industry navigates these challenges, it is clear that a harmonized global approach and the adoption of advanced technologies will be pivotal in shaping the future of infant nutrition research. By embracing these changes, the industry can ensure that infant formula remains a safe, effective, and trusted source of nutrition for babies worldwide.

Hit the CONTACT US button floating on this page for support from IQVIA Consumer Health on optimal study design, planning, execution, and regulatory compliance.

Related solutions

Contact Us